<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>MedyGenes | WGS Clinical Report</title>
  <style>
    :root {
      --bg: #f7f7f7;
      --panel: #ffffff;
      --text: #123C4E;
      --muted: #4c4c4c;
      --accent: #0CCA4A;
      --border: #dedede;
    }
    * { box-sizing: border-box; }
    body {
      margin: 0;
      font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
      background: var(--bg);
      color: var(--text);
      padding: 0;
    }
    @media screen {
      body {
        padding: 32px;
        display: flex;
        flex-direction: column;
        align-items: center;
      }
    }
    .page {
      width: 210mm;
      min-height: 297mm;
      background: var(--panel);
      padding: 36px 44px 48px;
      page-break-after: always;
      position: relative;
      border: 1px solid var(--border);
      box-shadow: 0 4px 12px rgba(0, 0, 0, 0.06);
      margin-bottom: 24px;
      overflow-x: hidden;
      box-sizing: border-box;
    }
    .page:last-child {
      page-break-after: auto;
    }
    .page::before {
      content: '';
      position: absolute;
      top: 0;
      left: 0;
      right: 0;
      height: 3px;
      background: linear-gradient(90deg, var(--accent) 0%, #0CCA4A80 100%);
    }
    .page-number {
      position: absolute;
      bottom: 20px;
      right: 44px;
      font-size: 11px;
      color: var(--muted);
      font-weight: 500;
      padding: 4px 8px;
      background: #f5f5f5;
      border-radius: 4px;
    }
    .topbar {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 32px;
      border-bottom: 3px solid #00B2FF;
      padding-bottom: 20px;
    }
    .brand {
      display: flex;
      flex-direction: column;
      align-items: flex-start;
      gap: 8px;
      font-weight: 700;
      letter-spacing: 0.4px;
    }
    .brand .mark {
      width: auto;
      height: 40px;
      display: flex;
      align-items: center;
    }
    .brand .mark img {
      height: 100%;
      width: auto;
      display: block;
    }
    .contact {
      text-align: right;
      font-size: 13px;
      color: var(--muted);
      line-height: 1.6;
    }
    .report-title-block {
      text-align: center;
      margin-bottom: 28px;
      padding: 24px;
      border-bottom: 3px solid #00B2FF;
      position: relative;
      background: linear-gradient(180deg, #f8f9fa 0%, #ffffff 100%);
      border-radius: 8px;
    }
    .report-title-top {
      font-size: 11px;
      color: var(--muted);
      margin: 0 0 10px 0;
      letter-spacing: 0.6px;
      text-transform: uppercase;
      display: flex;
      justify-content: center;
      align-items: center;
      gap: 16px;
      font-weight: 600;
    }
    .confidential-label {
      color: #9e1b1b;
      font-weight: 700;
      padding: 2px 8px;
      background: #fff4f4;
      border-radius: 4px;
    }
    .report-title {
      font-size: 32px;
      font-weight: 700;
      color: #00B2FF;
      margin: 0 0 10px 0;
      letter-spacing: 0.5px;
      line-height: 1.2;
    }
    .report-subtitle {
      font-size: 17px;
      color: var(--muted);
      margin: 0;
      font-weight: 500;
      letter-spacing: 0.2px;
    }
    .patient-specimen-grid {
      display: grid;
      grid-template-columns: 1fr 1fr;
      gap: 0;
      border: 1px solid var(--border);
      border-radius: 10px;
      overflow: hidden;
      margin-bottom: 28px;
      box-shadow: 0 1px 3px rgba(0, 0, 0, 0.05);
      background: #ffffff;
    }
    .patient-specimen-col {
      padding: 18px 20px;
      border-right: 1px solid #e8e8e8;
      background: #ffffff;
    }
    .patient-specimen-col:first-child {
      background: #f8f9fa;
    }
    .patient-specimen-col:last-child {
      border-right: none;
    }
    .patient-specimen-col .label {
      color: #4c4c4c;
      font-size: 11px;
      letter-spacing: 0.4px;
      text-transform: uppercase;
      margin-bottom: 6px;
      display: block;
      font-weight: 600;
    }
    .patient-specimen-col > div {
      margin-bottom: 14px;
      font-size: 14px;
      color: var(--text);
      font-weight: 500;
    }
    .patient-specimen-col > div:last-child {
      margin-bottom: 0;
    }
    .section {
      margin-bottom: 28px;
      padding: 24px 22px 20px;
      border: 1px solid var(--border);
      border-radius: 12px;
      background: #ffffff;
      box-shadow: 0 1px 3px rgba(0, 0, 0, 0.05);
      break-inside: avoid;
      page-break-inside: avoid;
      max-width: 100%;
    }
    /* Allow APPENDIX section to break across pages */
    section[class*="appendix"],
    section:has(h3:contains("APPENDIX")) {
      break-inside: auto;
      page-break-inside: auto;
    }
    .section h3 {
      margin: 0 0 18px;
      font-size: 17px;
      letter-spacing: 0.4px;
      text-transform: uppercase;
      color: #00B2FF;
      font-weight: 700;
      border-bottom: 3px solid #00B2FF;
      padding-bottom: 10px;
    }
    .section h4 {
      margin: 24px 0 12px 0;
      font-size: 15px;
      font-weight: 700;
      color: var(--text);
      letter-spacing: 0.2px;
      padding-bottom: 6px;
      border-bottom: 1px solid #e8e8e8;
    }
    .section h4:first-child {
      margin-top: 0;
    }
    .meta-grid {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 12px 18px;
      font-size: 14px;
      font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
    }
    .meta-grid > div > div {
      font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
      font-size: 14px;
      color: var(--text);
      font-weight: 400;
    }
    .meta-grid .label {
      color: var(--muted);
      font-size: 12px;
      letter-spacing: 0.3px;
      text-transform: uppercase;
      margin-bottom: 4px;
      display: block;
      font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
    }
    .findings-banner {
      background: #9e1b1b;
      border-radius: 8px;
      padding: 20px 24px;
      margin-bottom: 24px;
      display: flex;
      align-items: center;
      justify-content: flex-start;
      gap: 16px;
    }
    .findings-banner-icon {
      width: 40px;
      height: 40px;
      background: #ffd700;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      flex-shrink: 0;
      font-size: 24px;
      font-weight: 700;
      color: #9e1b1b;
    }
    .findings-banner-content {
      flex: 1;
      text-align: left;
    }
    .findings-banner h4 {
      margin: 0 0 8px 0;
      font-size: 18px;
      color: #ffffff;
      font-weight: 700;
      text-transform: uppercase;
      letter-spacing: 0.5px;
    }
    .findings-banner p {
      margin: 0;
      font-size: 14px;
      color: #ffffff;
      font-weight: 500;
    }
    .intro-section {
      margin-bottom: 24px;
      padding: 20px 22px;
      background: linear-gradient(180deg, #f0f7ff 0%, #ffffff 100%);
      border-left: 4px solid #00B2FF;
      border-radius: 8px;
      box-shadow: 0 1px 3px rgba(0, 0, 0, 0.05);
    }
    .intro-section p {
      margin: 0 0 12px 0;
      font-size: 14px;
      line-height: 1.7;
      color: var(--text);
    }
    .intro-section p:last-child {
      margin-bottom: 0;
    }
    .counts-summary {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 0;
      margin-top: 18px;
      border: 1px solid var(--border);
      border-radius: 10px;
      overflow: hidden;
      box-shadow: 0 1px 3px rgba(0, 0, 0, 0.05);
    }
    .count-item {
      background: #ffffff;
      border-right: 1px solid #e8e8e8;
      border-bottom: 1px solid #e8e8e8;
      padding: 16px 18px;
      display: flex;
      justify-content: space-between;
      align-items: center;
      transition: background-color 0.2s ease;
    }
    .count-item:hover {
      background: #f8f9fa;
    }
    .count-item:nth-child(even) {
      border-right: none;
    }
    .count-item:nth-child(n+3) {
      border-bottom: none;
    }
    .count-item .count-label {
      font-size: 13px;
      color: var(--muted);
      font-weight: 600;
      letter-spacing: 0.2px;
    }
    .count-item .count-value {
      font-size: 22px;
      font-weight: 700;
      color: #00B2FF;
    }
    table {
      width: 100%;
      max-width: 100%;
      border-collapse: collapse;
      font-size: 13px;
      margin-top: 12px;
      border: 1px solid var(--border);
      border-radius: 8px;
      overflow: hidden;
      box-shadow: 0 1px 3px rgba(0, 0, 0, 0.05);
      page-break-inside: auto;
      table-layout: fixed;
      word-wrap: break-word;
    }
    thead {
      background: linear-gradient(180deg, #1a1a1a 0%, #0f0f0f 100%);
      color: #fff;
    }
    th {
      padding: 14px 12px;
      text-align: left;
      vertical-align: middle;
      font-weight: 600;
      font-size: 12px;
      letter-spacing: 0.3px;
      text-transform: uppercase;
      border-bottom: 2px solid #333;
      word-wrap: break-word;
      overflow-wrap: break-word;
    }
    td {
      padding: 12px;
      border-bottom: 1px solid #e8e8e8;
      text-align: left;
      vertical-align: top;
      line-height: 1.5;
      word-wrap: break-word;
      overflow-wrap: break-word;
      hyphens: auto;
    }
    /* Specific styling for 10.4 table to prevent overflow - using inline styles in HTML instead */
    /* Ensure badges and status spans don't break */
    td .badge,
    td span[style*="CARRIER"],
    td span[style*="POSITIVE"],
    td span[style*="Negative"] {
      white-space: nowrap;
      display: inline-block;
    }
    /* Prevent line breaks in Result column cells - only for ACMG analysis tables */
    table.acmg-result-table tbody td:last-child {
      white-space: nowrap;
    }
    tbody tr {
      transition: background-color 0.2s ease;
    }
    tbody tr:nth-child(odd) { 
      background: #fafafa; 
    }
    tbody tr:hover {
      background: #f0f7ff;
    }
    tbody tr:last-child td {
      border-bottom: none;
    }
    tbody tr.positive-pathogenic {
      background: #fff4f4;
      border-left: 4px solid #9e1b1b;
    }
    tbody tr.positive-likely-pathogenic {
      background: #fff8e6;
      border-left: 4px solid #a06100;
    }
    tbody tr.carrier-status {
      background: #e8f4fd;
      border-left: 4px solid #00B2FF;
    }
    .badge {
      display: inline-block;
      padding: 5px 12px;
      border-radius: 12px;
      font-size: 11px;
      letter-spacing: 0.4px;
      font-weight: 700;
      text-transform: uppercase;
      box-shadow: 0 1px 2px rgba(0, 0, 0, 0.1);
      white-space: nowrap;
    }
    .badge.pathogenic {
      background: linear-gradient(180deg, #fff4f4 0%, #ffe8e8 100%);
      color: #9e1b1b;
      border: 1px solid #f4c4c4;
    }
    .badge.likely-pathogenic {
      background: linear-gradient(180deg, #fff8e6 0%, #fff4d6 100%);
      color: #a06100;
      border: 1px solid #f5d8a1;
    }
    .finding-card {
      border: 1px solid var(--border);
      border-radius: 10px;
      padding: 22px;
      background: #ffffff;
      box-shadow: 0 2px 6px rgba(0, 0, 0, 0.08);
      margin-bottom: 24px;
      border-left: 4px solid #00B2FF;
      break-inside: avoid;
      page-break-inside: avoid;
    }
    .finding-header {
      border-bottom: 2px solid #e8e8e8;
      padding-bottom: 14px;
      margin-bottom: 18px;
    }
    .finding-title {
      font-size: 17px;
      font-weight: 700;
      color: #00B2FF;
      margin: 0 0 6px 0;
      letter-spacing: 0.2px;
    }
    .finding-clinical-significance {
      font-size: 14px;
      color: var(--muted);
      font-style: italic;
    }
    .clinical-significance-below {
      margin-top: 16px;
      padding-top: 12px;
      border-top: 1px solid var(--border);
      font-size: 14px;
      font-weight: 600;
      color: var(--text);
    }
    .clinvar-stars {
      color: #ffa500;
      font-size: 14px;
      letter-spacing: 2px;
    }
    .key-value-table {
      width: 100%;
      max-width: 100%;
      border-collapse: collapse;
      margin-top: 12px;
      border: 1px solid #e8e8e8;
      border-radius: 8px;
      overflow: hidden;
      table-layout: auto;
      word-wrap: break-word;
    }
    .key-value-table td {
      padding: 10px 14px;
      border-bottom: 1px solid #e8e8e8;
      font-size: 13px;
      line-height: 1.6;
    }
    .key-value-table tr:last-child td {
      border-bottom: none;
    }
    .key-value-table td:first-child {
      font-weight: 600;
      color: #4c4c4c;
      width: 38%;
      text-transform: uppercase;
      font-size: 11px;
      letter-spacing: 0.4px;
      background: #f8f9fa;
      border-right: 1px solid #e8e8e8;
    }
    .key-value-table td:last-child {
      color: var(--text);
      font-weight: 500;
    }
    .notice-box {
      background: #fff8e6;
      border: 2px solid #000000;
      border-radius: 8px;
      padding: 16px 20px;
      margin-bottom: 20px;
      display: flex;
      align-items: flex-start;
      gap: 12px;
    }
    .notice-box-icon {
      width: 24px;
      height: 24px;
      background: #ffd700;
      border-radius: 4px;
      display: flex;
      align-items: center;
      justify-content: center;
      flex-shrink: 0;
      font-size: 16px;
      font-weight: 700;
      color: #000000;
      clip-path: polygon(50% 0%, 0% 100%, 100% 100%);
    }
    .notice-box-content {
      flex: 1;
    }
    .notice-box h4 {
      margin: 0 0 8px 0;
      font-size: 16px;
      color: #000000;
      font-weight: 700;
    }
    .notice-box p {
      margin: 0;
      font-size: 14px;
      color: var(--text);
      line-height: 1.6;
    }
    .detail-link {
      color: var(--accent);
      text-decoration: underline;
      font-weight: 700;
    }
    .detail-link:hover { text-decoration: underline; }
    .recommendations-list {
      list-style: none;
      padding: 0;
      margin: 18px 0;
    }
    .recommendations-list li {
      padding: 10px 0 10px 28px;
      position: relative;
      font-size: 14px;
      line-height: 1.7;
      color: var(--text);
      border-left: 2px solid transparent;
      transition: all 0.2s ease;
    }
    .recommendations-list li:hover {
      border-left-color: #00B2FF;
      padding-left: 32px;
    }
    .recommendations-list li::before {
      content: '▸';
      position: absolute;
      left: 10px;
      color: #00B2FF;
      font-weight: 700;
      font-size: 14px;
    }
    .methodology-table {
      width: 100%;
      max-width: 100%;
      border-collapse: collapse;
      margin-top: 14px;
      border: 1px solid var(--border);
      border-radius: 8px;
      overflow: hidden;
      table-layout: auto;
      word-wrap: break-word;
    }
    .methodology-table td {
      padding: 12px 16px;
      border-bottom: 1px solid #e8e8e8;
      font-size: 13px;
      line-height: 1.6;
    }
    .methodology-table tr:last-child td {
      border-bottom: none;
    }
    .methodology-table td:first-child {
      font-weight: 600;
      color: #4c4c4c;
      width: 42%;
      background: #f8f9fa;
      border-right: 1px solid #e8e8e8;
      letter-spacing: 0.2px;
    }
    .methodology-table td:last-child {
      color: var(--text);
      font-weight: 500;
    }
    .footer {
      margin-top: 36px;
      display: flex;
      justify-content: space-between;
      color: var(--muted);
      font-size: 12px;
    }
    .signature-block {
      margin-top: 40px;
      padding-top: 32px;
      border-top: 2px solid var(--border);
    }
    .signature-line {
      margin-bottom: 24px;
    }
    .signature-line .signature-name {
      font-weight: 700;
      font-size: 14px;
      color: var(--text);
      margin-bottom: 4px;
    }
    .signature-line .signature-credentials {
      font-size: 12px;
      color: var(--muted);
      margin-bottom: 8px;
    }
    .signature-line .signature-date {
      font-size: 12px;
      color: var(--muted);
    }
    @page {
      size: A4;
      margin: 0;
    }
    @media print {
      body { 
        background: #fff; 
        padding: 0;
        margin: 0;
      }
      .page { 
        box-shadow: none; 
        border: 1px solid #e0e0e0; 
        width: 210mm;
        height: 297mm;
        min-height: 297mm;
        margin: 0;
        padding: 36px 44px 48px;
        page-break-after: always;
      }
      .page:last-child {
        page-break-after: auto;
        min-height: auto;
      }
      .section { 
        break-inside: avoid; 
        page-break-inside: avoid;
        margin-bottom: 20px;
        orphans: 3;
        widows: 3;
      }
      .section[style*="break-inside: auto"] {
        break-inside: auto;
        page-break-inside: auto;
      }
      /* Allow APPENDIX tables to break */
      section[style*="break-inside: auto"] table {
        page-break-inside: auto;
      }
      .finding-card { 
        break-inside: avoid; 
        page-break-inside: avoid;
        orphans: 3;
        widows: 3;
      }
      table {
        page-break-inside: auto;
      }
      thead {
        display: table-header-group;
      }
      tbody {
        display: table-row-group;
      }
      tr {
        page-break-inside: avoid;
        page-break-after: auto;
      }
      td, th {
        page-break-inside: avoid;
      }
      /* Allow tables to break across pages but keep header visible */
      table {
        page-break-inside: auto;
      }
      thead tr {
        page-break-after: avoid;
        page-break-inside: avoid;
      }
      tbody tr {
        page-break-inside: avoid;
      }
      .patient-specimen-grid {
        break-inside: avoid;
        page-break-inside: avoid;
      }
      .counts-summary {
        break-inside: avoid;
        page-break-inside: avoid;
      }
      .intro-section {
        break-inside: avoid;
        page-break-inside: avoid;
      }
      .findings-banner {
        break-inside: avoid;
        page-break-inside: avoid;
      }
      .notice-box {
        break-inside: avoid;
        page-break-inside: avoid;
      }
      .recommendations-list {
        break-inside: auto;
      }
      .recommendations-list li {
        page-break-inside: avoid;
      }
      .signature-block {
        break-inside: avoid;
        page-break-inside: avoid;
      }
      .key-value-table {
        page-break-inside: auto;
      }
      .key-value-table tr {
        page-break-inside: avoid;
      }
      .methodology-table {
        page-break-inside: auto;
      }
      .methodology-table tr {
        page-break-inside: avoid;
      }
    }
  </style>
</head>
<body>
  <!-- Page 1: Patient Information & Executive Summary -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B0: Report Title Block -->
    <div class="report-title-block">
      <div class="report-title-top">
        <span>WHOLE GENOME SEQUENCING - CLINICAL REPORT</span>
        <span class="confidential-label">CONFIDENTIAL</span>
      </div>
      <h1 class="report-title">WHOLE GENOME SEQUENCING</h1>
      <p class="report-subtitle">Clinical Report - ACMG Secondary Findings Analysis</p>
    </div>

    <!-- B1: Patient / Sample Header -->
    <div class="patient-specimen-grid">
      <div class="patient-specimen-col">
        <div>
          <span class="label">Patient Name:</span>
          <div>[PATIENT NAME]</div>
        </div>
        <div>
          <span class="label">Date of Birth:</span>
          <div>[DOB]</div>
        </div>
        <div>
          <span class="label">Sex:</span>
          <div>[M/F]</div>
        </div>
        <div>
          <span class="label">Ethnicity:</span>
          <div>[ETHNICITY]</div>
        </div>
      </div>
      <div class="patient-specimen-col">
        <div>
          <span class="label">Specimen ID:</span>
          <div>WGS-2024-12345</div>
        </div>
        <div>
          <span class="label">Specimen Type:</span>
          <div>Peripheral Blood</div>
        </div>
        <div>
          <span class="label">Collection Date:</span>
          <div>[DATE]</div>
        </div>
        <div>
          <span class="label">Report Date:</span>
          <div>2025-12-16</div>
        </div>
      </div>
    </div>

    <!-- B2: Clinically Significant Findings Banner (Conditional) -->
    <div class="findings-banner">
      <div class="findings-banner-icon">⚠</div>
      <div class="findings-banner-content">
        <h4>CLINICALLY SIGNIFICANT FINDINGS DETECTED</h4>
        <p>This report contains PATHOGENIC and/or LIKELY PATHOGENIC variants. Genetic counseling is strongly recommended. See detailed findings below.</p>
      </div>
    </div>

    <!-- B3: Executive Summary -->
    <section class="section">
      <h3>1. EXECUTIVE SUMMARY</h3>
      <div class="intro-section">
        <p>This whole genome sequencing analysis was performed to screen for secondary findings in 81 genes recommended by ACMG SF v3.2. The analysis identified clinically significant findings that require follow-up.</p>
      </div>
      <div class="counts-summary">
        <div class="count-item">
          <span class="count-label">Pathogenic Variants:</span>
          <span class="count-value">3</span>
        </div>
        <div class="count-item">
          <span class="count-label">Likely Pathogenic Variants:</span>
          <span class="count-value">1</span>
        </div>
        <div class="count-item">
          <span class="count-label">Carrier Status (AR conditions):</span>
          <span class="count-value">1</span>
        </div>
        <div class="count-item">
          <span class="count-label">Variants of Uncertain Significance:</span>
          <span class="count-value">1</span>
        </div>
      </div>
    </section>
    <div class="page-number">Page 1</div>
  </main>

  <!-- Page 1 Continued: Pathogenic/Likely Pathogenic Findings Summary Table -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B4: Pathogenic / Likely Pathogenic Findings -->
    <section class="section">
      <h3>2. PATHOGENIC/LIKELY PATHOGENIC FINDINGS</h3>
      <p style="margin: 0 0 16px 0; font-size: 14px; color: var(--text);">The following clinically significant variants were identified:</p>
      
      <!-- B4.1: Summary Table -->
      <table>
        <thead>
          <tr>
            <th>Gene</th>
            <th>Variant (cDNA)</th>
            <th>Protein</th>
            <th>Zygosity</th>
            <th>Class.</th>
            <th>ACMG Criteria</th>
            <th>ClinVar ID</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>BRCA1</td>
            <td>c.5266dupC</td>
            <td>p.Gln1756ProfsTer74</td>
            <td>Heterozygous</td>
            <td><span class="badge pathogenic">P</span></td>
            <td>PVS1, PM2, PP5</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/17661" target="_blank" class="detail-link">VCV000017661</a></td>
          </tr>
          <tr>
            <td>LDLR</td>
            <td>c.682G>A</td>
            <td>p.Glu228Lys</td>
            <td>Heterozygous</td>
            <td><span class="badge pathogenic">P</span></td>
            <td>PS3, PM1, PM2, PP3, PP5</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/3764" target="_blank" class="detail-link">VCV000003764</a></td>
          </tr>
          <tr>
            <td>HFE</td>
            <td>c.845G>A</td>
            <td>p.Cys282Tyr</td>
            <td>Homozygous</td>
            <td><span class="badge pathogenic">P</span></td>
            <td>PS1, PS3, PM2, PP5</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/3827" target="_blank" class="detail-link">VCV000003827</a></td>
          </tr>
          <tr>
            <td>RYR1</td>
            <td>c.7300G>A</td>
            <td>p.Gly2434Arg</td>
            <td>Heterozygous</td>
            <td><span class="badge likely-pathogenic">LP</span></td>
            <td>PM1, PM2, PP3, PP5</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/4063" target="_blank" class="detail-link">VCV000004063</a></td>
          </tr>
        </tbody>
      </table>
    </section>

    <!-- B4.2: Detailed Variant Reports - Finding 1 -->
    <section class="section" style="border: none; padding: 0;">
      <h3 style="margin-bottom: 16px;">2.1 Detailed Variant Reports</h3>
      
      <div class="finding-card" id="finding-1">
        <div class="finding-header">
          <div class="finding-title">Finding 1: BRCA1 – Pathogenic</div>
        </div>
        <table class="key-value-table">
          <tr>
            <td>Gene (HGNC)</td>
            <td>BRCA1</td>
          </tr>
          <tr>
            <td>Transcript</td>
            <td>NM_007294.4</td>
          </tr>
          <tr>
            <td>Genomic Location</td>
            <td>chr17:43057062 (GRCh38)</td>
          </tr>
          <tr>
            <td>cDNA Change (HGVS)</td>
            <td>c.5266dupC</td>
          </tr>
          <tr>
            <td>Protein Change (HGVS)</td>
            <td>p.Gln1756ProfsTer74</td>
          </tr>
          <tr>
            <td>Zygosity</td>
            <td>Heterozygous</td>
          </tr>
          <tr>
            <td>Classification</td>
            <td><span class="badge pathogenic">Pathogenic</span></td>
          </tr>
          <tr>
            <td>ACMG/AMP Criteria Applied</td>
            <td>PVS1, PM2, PP5</td>
          </tr>
          <tr>
            <td>ClinVar ID</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/17661" target="_blank" class="detail-link">VCV000017661</a></td>
          </tr>
          <tr>
            <td>ClinVar Review Status</td>
            <td><span class="clinvar-stars">★★★★</span> (Expert panel)</td>
          </tr>
          <tr>
            <td>dbSNP ID</td>
            <td>rs80357906</td>
          </tr>
          <tr>
            <td>gnomAD Allele Frequency</td>
            <td>0.00002 (2/141,456)</td>
          </tr>
          <tr>
            <td>gnomAD Popmax</td>
            <td>0.00004 (Ashkenazi Jewish)</td>
          </tr>
          <tr>
            <td>CADD Score</td>
            <td>35</td>
          </tr>
          <tr>
            <td>REVEL Score</td>
            <td>N/A (frameshift)</td>
          </tr>
          <tr>
            <td>SpliceAI Score</td>
            <td>N/A</td>
          </tr>
          <tr>
            <td>Associated Condition</td>
            <td>Hereditary Breast and Ovarian Cancer Syndrome</td>
          </tr>
          <tr>
            <td>Inheritance Pattern</td>
            <td>AD</td>
          </tr>
          <tr>
            <td>ClinGen Gene-Disease Validity</td>
            <td>Definitive</td>
          </tr>
          <tr>
            <td>Key Publications</td>
            <td>PMID: 8524414, 9042909, 20104584</td>
          </tr>
        </table>
        <div class="clinical-significance-below">
          <strong>Clinical Significance:</strong> Hereditary Breast and Ovarian Cancer Syndrome
        </div>
      </div>
      
      <div class="finding-card" id="finding-2" style="margin-top: 24px;">
        <div class="finding-header">
          <div class="finding-title">Finding 2: LDLR – Pathogenic</div>
        </div>
        <table class="key-value-table">
          <tr>
            <td>Gene (HGNC)</td>
            <td>LDLR</td>
          </tr>
          <tr>
            <td>Transcript</td>
            <td>NM_000527.5</td>
          </tr>
          <tr>
            <td>Genomic Location</td>
            <td>chr19:11113314 (GRCh38)</td>
          </tr>
          <tr>
            <td>cDNA Change (HGVS)</td>
            <td>c.682G>A</td>
          </tr>
          <tr>
            <td>Protein Change (HGVS)</td>
            <td>p.Glu228Lys</td>
          </tr>
          <tr>
            <td>Zygosity</td>
            <td>Heterozygous</td>
          </tr>
          <tr>
            <td>Classification</td>
            <td><span class="badge pathogenic">Pathogenic</span></td>
          </tr>
          <tr>
            <td>ACMG/AMP Criteria Applied</td>
            <td>PS3, PM1, PM2, PP3, PP5</td>
          </tr>
          <tr>
            <td>ClinVar ID</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/3764" target="_blank" class="detail-link">VCV000003764</a></td>
          </tr>
          <tr>
            <td>ClinVar Review Status</td>
            <td><span class="clinvar-stars">★★★★</span> (Expert panel)</td>
          </tr>
          <tr>
            <td>dbSNP ID</td>
            <td>rs28942078</td>
          </tr>
          <tr>
            <td>gnomAD Allele Frequency</td>
            <td>0.00001 (1/141,456)</td>
          </tr>
          <tr>
            <td>gnomAD Popmax</td>
            <td>0.00003 (European)</td>
          </tr>
          <tr>
            <td>CADD Score</td>
            <td>28.5</td>
          </tr>
          <tr>
            <td>REVEL Score</td>
            <td>0.876</td>
          </tr>
          <tr>
            <td>SpliceAI Score</td>
            <td>0.01</td>
          </tr>
          <tr>
            <td>Associated Condition</td>
            <td>Familial Hypercholesterolemia</td>
          </tr>
          <tr>
            <td>Inheritance Pattern</td>
            <td>AD/SD</td>
          </tr>
          <tr>
            <td>ClinGen Gene-Disease Validity</td>
            <td>Definitive</td>
          </tr>
          <tr>
            <td>Key Publications</td>
            <td>PMID: 2563166, 20301655, 28405004</td>
          </tr>
        </table>
        <div class="clinical-significance-below">
          <strong>Clinical Significance:</strong> Familial Hypercholesterolemia
        </div>
      </div>
    </section>
    <div class="page-number">Page 2</div>
  </main>

  <!-- Page 3: Pathogenic/Likely Pathogenic Findings - Finding 3 & 4 & Carrier Status -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B4.2: Detailed Variant Reports - Finding 3 & 4 -->
    <section class="section" style="border: none; padding: 0;">
      <div class="finding-card" id="finding-3">
        <div class="finding-header">
          <div class="finding-title">Finding 3: HFE – Pathogenic</div>
        </div>
        <table class="key-value-table">
          <tr>
            <td>Gene (HGNC)</td>
            <td>HFE</td>
          </tr>
          <tr>
            <td>Transcript</td>
            <td>NM_000410.5</td>
          </tr>
          <tr>
            <td>Genomic Location</td>
            <td>chr6:26093141 (GRCh38)</td>
          </tr>
          <tr>
            <td>cDNA Change (HGVS)</td>
            <td>c.845G>A</td>
          </tr>
          <tr>
            <td>Protein Change (HGVS)</td>
            <td>p.Cys282Tyr</td>
          </tr>
          <tr>
            <td>Zygosity</td>
            <td>Homozygous</td>
          </tr>
          <tr>
            <td>Classification</td>
            <td><span class="badge pathogenic">Pathogenic</span></td>
          </tr>
          <tr>
            <td>ACMG/AMP Criteria Applied</td>
            <td>PS1, PS3, PM2, PP5</td>
          </tr>
          <tr>
            <td>ClinVar ID</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/3827" target="_blank" class="detail-link">VCV000003827</a></td>
          </tr>
          <tr>
            <td>ClinVar Review Status</td>
            <td><span class="clinvar-stars">★★★★</span> (Expert panel)</td>
          </tr>
          <tr>
            <td>dbSNP ID</td>
            <td>rs1800562</td>
          </tr>
          <tr>
            <td>gnomAD Allele Frequency</td>
            <td>0.031 (4,378/141,456)</td>
          </tr>
          <tr>
            <td>gnomAD Popmax</td>
            <td>0.062 (European)</td>
          </tr>
          <tr>
            <td>CADD Score</td>
            <td>23.5</td>
          </tr>
          <tr>
            <td>REVEL Score</td>
            <td>0.523</td>
          </tr>
          <tr>
            <td>SpliceAI Score</td>
            <td>0.00</td>
          </tr>
          <tr>
            <td>Associated Condition</td>
            <td>Hereditary Hemochromatosis</td>
          </tr>
          <tr>
            <td>Inheritance Pattern</td>
            <td>AR</td>
          </tr>
          <tr>
            <td>ClinGen Gene-Disease Validity</td>
            <td>Definitive</td>
          </tr>
          <tr>
            <td>Key Publications</td>
            <td>PMID: 7585954, 20301655</td>
          </tr>
        </table>
        <div class="clinical-significance-below">
          <strong>Clinical Significance:</strong> Hereditary Hemochromatosis
        </div>
      </div>
      
      <div class="finding-card" id="finding-4" style="margin-top: 24px;">
        <div class="finding-header">
          <div class="finding-title">Finding 4: RYR1 – Likely Pathogenic</div>
        </div>
        <table class="key-value-table">
          <tr>
            <td>Gene (HGNC)</td>
            <td>RYR1</td>
          </tr>
          <tr>
            <td>Transcript</td>
            <td>NM_000540.3</td>
          </tr>
          <tr>
            <td>Genomic Location</td>
            <td>chr19:38959789 (GRCh38)</td>
          </tr>
          <tr>
            <td>cDNA Change (HGVS)</td>
            <td>c.7300G>A</td>
          </tr>
          <tr>
            <td>Protein Change (HGVS)</td>
            <td>p.Gly2434Arg</td>
          </tr>
          <tr>
            <td>Zygosity</td>
            <td>Heterozygous</td>
          </tr>
          <tr>
            <td>Classification</td>
            <td><span class="badge likely-pathogenic">Likely Pathogenic</span></td>
          </tr>
          <tr>
            <td>ACMG/AMP Criteria Applied</td>
            <td>PM1, PM2, PP3, PP5</td>
          </tr>
          <tr>
            <td>ClinVar ID</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/4063" target="_blank" class="detail-link">VCV000004063</a></td>
          </tr>
          <tr>
            <td>ClinVar Review Status</td>
            <td><span class="clinvar-stars">★★★</span> (2 submitters)</td>
          </tr>
          <tr>
            <td>dbSNP ID</td>
            <td>rs121918593</td>
          </tr>
          <tr>
            <td>gnomAD Allele Frequency</td>
            <td>0.00001 (1/141,456)</td>
          </tr>
          <tr>
            <td>gnomAD Popmax</td>
            <td>0.00002 (European)</td>
          </tr>
          <tr>
            <td>CADD Score</td>
            <td>26.3</td>
          </tr>
          <tr>
            <td>REVEL Score</td>
            <td>0.812</td>
          </tr>
          <tr>
            <td>SpliceAI Score</td>
            <td>0.02</td>
          </tr>
          <tr>
            <td>Associated Condition</td>
            <td>Malignant Hyperthermia Susceptibility</td>
          </tr>
          <tr>
            <td>Inheritance Pattern</td>
            <td>AD</td>
          </tr>
          <tr>
            <td>ClinGen Gene-Disease Validity</td>
            <td>Definitive</td>
          </tr>
          <tr>
            <td>Key Publications</td>
            <td>PMID: 7647791, 14706354</td>
          </tr>
        </table>
        <div class="clinical-significance-below">
          <strong>Clinical Significance:</strong> Malignant Hyperthermia Susceptibility
        </div>
      </div>
    </section>

    <!-- B5: Carrier Status -->
    <section class="section">
      <h3>3. CARRIER STATUS (Autosomal Recessive Conditions)</h3>
      <p style="margin: 0 0 16px 0; font-size: 14px; color: var(--text); line-height: 1.6;">
        The following heterozygous pathogenic variants were identified in genes associated with autosomal recessive conditions. These findings indicate carrier status only and do not cause disease in the heterozygous state.
      </p>
      <table>
        <thead>
          <tr>
            <th>Gene</th>
            <th>Variant (cDNA)</th>
            <th>Protein</th>
            <th>Condition</th>
            <th>Inheritance</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>MUTYH</td>
            <td>c.536A>G</td>
            <td>p.Tyr179Cys</td>
            <td>MUTYH-associated polyposis (MAP)</td>
            <td>AR</td>
          </tr>
        </tbody>
      </table>
      <div style="margin-top: 16px; padding-top: 12px; border-top: 1px solid var(--border);">
        <div style="font-weight: 600; font-size: 14px; color: var(--text); margin-bottom: 8px;">Clinical Implication:</div>
        <div style="font-size: 14px; color: var(--text); line-height: 1.6; margin-bottom: 12px;">
          Carrier testing for reproductive partners may be considered. Genetic counseling is recommended for family planning discussions.
        </div>
      </div>
    </section>
    <div class="page-number">Page 3</div>
  </main>

  <!-- Page 4: VUS + ACMG Gene Analysis -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B6: Variants of Uncertain Significance -->
    <section class="section">
      <h3>4. VARIANTS OF UNCERTAIN SIGNIFICANCE (VUS)</h3>
      <div class="notice-box">
        <div class="notice-box-icon">⚠</div>
        <div class="notice-box-content">
          <h4>**IMPORTANT NOTICE**</h4>
          <p><strong>VUS should NOT be used for clinical decision-making.</strong> These variants may be reclassified as more data becomes available. Periodic re-evaluation is recommended.</p>
        </div>
      </div>
      <table>
        <thead>
          <tr>
            <th>Gene</th>
            <th>Variant</th>
            <th>Protein</th>
            <th>ClinVar</th>
            <th>gnomAD</th>
            <th>CADD</th>
            <th>Condition</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>MYBPC3</td>
            <td>c.2159G>A</td>
            <td>p.Arg720Gln</td>
            <td><a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/12547" target="_blank" class="detail-link">VCV000012547</a></td>
            <td>0.00005</td>
            <td>23.4</td>
            <td>Hypertrophic Cardiomyopathy</td>
          </tr>
        </tbody>
      </table>
    </section>

    <!-- B7: ACMG Secondary Findings Gene Analysis -->
    <section class="section">
      <h3>5. ACMG SECONDARY FINDINGS ANALYSIS</h3>
      <p style="margin: 0 0 16px 0; font-size: 14px; color: var(--text); line-height: 1.6;">
        Complete analysis of 81 genes recommended by ACMG SF v3.2 for secondary findings reporting.
      </p>
      
      <h4 style="margin: 16px 0 8px 0; font-size: 14px; font-weight: 600;">5.1 Cancer Predisposition Genes (28 genes)</h4>
      <table class="acmg-result-table">
        <thead>
          <tr>
            <th>Gene</th>
            <th>Associated Condition</th>
            <th>Inheritance</th>
            <th>Result</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>APC</td>
            <td>Familial adenomatous polyposis</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>BMPR1A</td>
            <td>Juvenile polyposis syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr class="positive-pathogenic">
            <td>BRCA1</td>
            <td>Hereditary breast/ovarian cancer</td>
            <td>AD</td>
            <td><span class="badge pathogenic">POSITIVE (P)</span></td>
          </tr>
          <tr>
            <td>BRCA2</td>
            <td>Hereditary breast/ovarian cancer</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MAX</td>
            <td>Hereditary paraganglioma-pheochromocytoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MEN1</td>
            <td>Multiple endocrine neoplasia type 1</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MLH1</td>
            <td>Lynch syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MSH2</td>
            <td>Lynch syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MSH6</td>
            <td>Lynch syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr class="carrier-status">
            <td>MUTYH</td>
            <td>MUTYH-associated polyposis</td>
            <td>AR</td>
            <td><span style="color: #00B2FF; font-weight: 600; white-space: nowrap;">CARRIER</span></td>
          </tr>
          <tr>
            <td>NF2</td>
            <td>Neurofibromatosis type 2</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>PALB2</td>
            <td>Hereditary breast cancer</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>PMS2</td>
            <td>Lynch syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>PTEN</td>
            <td>PTEN hamartoma tumor syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>RB1</td>
            <td>Retinoblastoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>RET</td>
            <td>MEN2, Familial medullary thyroid cancer</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SDHAF2</td>
            <td>Hereditary paraganglioma-pheochromocytoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SDHB</td>
            <td>Hereditary paraganglioma-pheochromocytoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SDHC</td>
            <td>Hereditary paraganglioma-pheochromocytoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SDHD</td>
            <td>Hereditary paraganglioma-pheochromocytoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SMAD4</td>
            <td>Juvenile polyposis syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>STK11</td>
            <td>Peutz-Jeghers syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TMEM127</td>
            <td>Hereditary paraganglioma-pheochromocytoma</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TP53</td>
            <td>Li-Fraumeni syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TSC1</td>
            <td>Tuberous sclerosis complex</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TSC2</td>
            <td>Tuberous sclerosis complex</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>VHL</td>
            <td>Von Hippel-Lindau syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>WT1</td>
            <td>Wilms tumor predisposition</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
        </tbody>
      </table>

      <h4 style="margin: 24px 0 8px 0; font-size: 14px; font-weight: 600;">5.2 Cardiovascular Genes (42 genes)</h4>
      <table class="acmg-result-table">
        <thead>
          <tr>
            <th>Gene</th>
            <th>Associated Condition</th>
            <th>Inheritance</th>
            <th>Result</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>ACTA2</td>
            <td>Thoracic aortic aneurysm</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ACTC1</td>
            <td>Hypertrophic/Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>APOB</td>
            <td>Familial hypercholesterolemia</td>
            <td>AD/SD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CALM1</td>
            <td>Long QT syndrome, CPVT</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CALM2</td>
            <td>Long QT syndrome, CPVT</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CALM3</td>
            <td>Long QT syndrome, CPVT</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>FBN1</td>
            <td>Marfan syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYBPC3</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr class="positive-pathogenic">
            <td>LDLR</td>
            <td>Familial hypercholesterolemia</td>
            <td>AD/SD</td>
            <td><span class="badge pathogenic">POSITIVE (P)</span></td>
          </tr>
          <tr>
            <td>PCSK9</td>
            <td>Familial hypercholesterolemia</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TTN</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TTR</td>
            <td>Hereditary transthyretin amyloidosis</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYH7</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>KCNQ1</td>
            <td>Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>KCNH2</td>
            <td>Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SCN5A</td>
            <td>Brugada syndrome, Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>RYR2</td>
            <td>Catecholaminergic polymorphic ventricular tachycardia</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>LMNA</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>PKP2</td>
            <td>Arrhythmogenic right ventricular cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>DSP</td>
            <td>Arrhythmogenic right ventricular cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>DSG2</td>
            <td>Arrhythmogenic right ventricular cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TMEM43</td>
            <td>Arrhythmogenic right ventricular cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYH11</td>
            <td>Thoracic aortic aneurysm</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>COL3A1</td>
            <td>Ehlers-Danlos syndrome type IV</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>FBN2</td>
            <td>Congenital contractural arachnodactyly</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SMAD3</td>
            <td>Loeys-Dietz syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TGFBR1</td>
            <td>Loeys-Dietz syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TGFBR2</td>
            <td>Loeys-Dietz syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>GLA</td>
            <td>Fabry disease</td>
            <td>XL</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>PRKAG2</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TNNT2</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TNNI3</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TPM1</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ACTN2</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CASQ2</td>
            <td>Catecholaminergic polymorphic ventricular tachycardia</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ANK2</td>
            <td>Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>KCNE1</td>
            <td>Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>KCNE2</td>
            <td>Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>KCNJ2</td>
            <td>Andersen-Tawil syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CACNA1C</td>
            <td>Timothy syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SCN1B</td>
            <td>Brugada syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>SCN4B</td>
            <td>Long QT syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TRPM4</td>
            <td>Brugada syndrome</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ABCC9</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>DES</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>FLNC</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>PLN</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>BAG3</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CRYAB</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>LDB3</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>RBM20</td>
            <td>Dilated cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TNNC1</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYL2</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYL3</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>JPH2</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>CSRP3</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>TCAP</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>VCL</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>OBSCN</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYOZ2</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ANKRD1</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>NEXN</td>
            <td>Hypertrophic cardiomyopathy</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>MYLK</td>
            <td>Thoracic aortic aneurysm</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>LOX</td>
            <td>Thoracic aortic aneurysm</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>EFEMP2</td>
            <td>Cutis laxa</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>FBLN5</td>
            <td>Cutis laxa</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ELN</td>
            <td>Cutis laxa</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>NOTCH1</td>
            <td>Aortic valve disease</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
        </tbody>
      </table>

      <h4 style="margin: 24px 0 8px 0; font-size: 14px; font-weight: 600;">5.3 Inborn Errors of Metabolism (6 genes)</h4>
      <table class="acmg-result-table">
        <thead>
          <tr>
            <th>Gene</th>
            <th>Associated Condition</th>
            <th>Inheritance</th>
            <th>Result</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>ATP7B</td>
            <td>Wilson disease</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>BTD</td>
            <td>Biotinidase deficiency</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>GAA</td>
            <td>Pompe disease</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>GLA</td>
            <td>Fabry disease</td>
            <td>XL</td>
            <td>Negative</td>
          </tr>
          <tr class="positive-pathogenic">
            <td>HFE</td>
            <td>Hereditary hemochromatosis</td>
            <td>AR</td>
            <td><span class="badge pathogenic">POSITIVE (P)</span></td>
          </tr>
          <tr>
            <td>OTC</td>
            <td>Ornithine transcarbamylase deficiency</td>
            <td>XL</td>
            <td>Negative</td>
          </tr>
        </tbody>
      </table>

      <h4 style="margin: 24px 0 8px 0; font-size: 14px; font-weight: 600;">5.4 Miscellaneous Conditions (5 genes)</h4>
      <table class="acmg-result-table">
        <thead>
          <tr>
            <th>Gene</th>
            <th>Associated Condition</th>
            <th>Inheritance</th>
            <th>Result</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>ACVRL1</td>
            <td>Hereditary hemorrhagic telangiectasia</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>ENG</td>
            <td>Hereditary hemorrhagic telangiectasia</td>
            <td>AD</td>
            <td>Negative</td>
          </tr>
          <tr>
            <td>RPE65</td>
            <td>RPE65-related retinal dystrophy</td>
            <td>AR</td>
            <td>Negative</td>
          </tr>
          <tr class="positive-likely-pathogenic">
            <td>RYR1</td>
            <td>Malignant hyperthermia susceptibility</td>
            <td>AD/AR</td>
            <td><span class="badge likely-pathogenic">POSITIVE (LP)</span></td>
          </tr>
        </tbody>
      </table>
    </section>
    <div class="page-number">Page 4</div>
  </main>

  <!-- Page 5: Clinical Recommendations + Methodology -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B8: Clinical Recommendations -->
    <section class="section">
      <h3>6. CLINICAL RECOMMENDATIONS</h3>
      
      <div style="margin-bottom: 24px;">
        <h4 style="margin: 0 0 12px 0; font-size: 15px; font-weight: 600; color: var(--text);">6.1 BRCA1 - Hereditary Breast and Ovarian Cancer</h4>
        <ul class="recommendations-list">
          <li>Referral to oncology/high-risk breast clinic</li>
          <li>Enhanced breast cancer screening (MRI + mammography from age 25)</li>
          <li>Discussion of risk-reducing surgical options</li>
          <li>Cascade genetic testing for at-risk family members</li>
          <li>Consider PARP inhibitor eligibility if cancer develops</li>
        </ul>
      </div>

      <div style="margin-bottom: 24px;">
        <h4 style="margin: 0 0 12px 0; font-size: 15px; font-weight: 600; color: var(--text);">6.2 LDLR - Familial Hypercholesterolemia</h4>
        <ul class="recommendations-list">
          <li>Lipid panel and cardiovascular risk assessment</li>
          <li>Initiation of high-intensity statin therapy</li>
          <li>Referral to lipid specialist/cardiologist</li>
          <li>Screening of first-degree relatives</li>
          <li>Consider PCSK9 inhibitors if LDL-C target not achieved</li>
        </ul>
      </div>

      <div style="margin-bottom: 24px;">
        <h4 style="margin: 0 0 12px 0; font-size: 15px; font-weight: 600; color: var(--text);">6.3 HFE - Hereditary Hemochromatosis</h4>
        <ul class="recommendations-list">
          <li>Serum ferritin and transferrin saturation monitoring</li>
          <li>Therapeutic phlebotomy if iron overload present</li>
          <li>Liver function monitoring</li>
          <li>Referral to hepatologist/hematologist</li>
          <li>Avoid iron supplements and vitamin C with meals</li>
        </ul>
      </div>

      <div>
        <h4 style="margin: 0 0 12px 0; font-size: 15px; font-weight: 600; color: var(--text);">6.4 RYR1 - Malignant Hyperthermia Susceptibility</h4>
        <ul class="recommendations-list">
          <li>Medical alert bracelet recommended</li>
          <li>Avoid triggering anesthetic agents (volatile anesthetics, succinylcholine)</li>
          <li>Inform anesthesiologist before any surgical procedure</li>
          <li>Pre-surgical consultation with anesthesia team</li>
          <li>Consider in vitro contracture test (IVCT) for confirmation</li>
        </ul>
      </div>
      
    </section>

    <!-- B9: Methodology -->
    <section class="section">
      <h3>7. METHODOLOGY</h3>
      <table class="methodology-table">
        <tr>
          <td>Sequencing Platform</td>
          <td>Illumina NovaSeq 6000</td>
        </tr>
        <tr>
          <td>Library Preparation</td>
          <td>Illumina DNA Prep with Enrichment</td>
        </tr>
        <tr>
          <td>Mean Coverage</td>
          <td>>30x across genome</td>
        </tr>
        <tr>
          <td>Reference Genome</td>
          <td>GRCh38/hg38</td>
        </tr>
        <tr>
          <td>Alignment</td>
          <td>BWA-MEM2 v2.2.1</td>
        </tr>
        <tr>
          <td>Variant Calling</td>
          <td>GATK HaplotypeCaller v4.4</td>
        </tr>
        <tr>
          <td>Annotation</td>
          <td>VEP, ANNOVAR, InterVar</td>
        </tr>
        <tr>
          <td>Quality Metrics</td>
          <td>≥99% bases ≥20x coverage</td>
        </tr>
        <tr>
          <td>Confirmation Method</td>
          <td>Sanger sequencing for P/LP variants</td>
        </tr>
      </table>
    </section>

    <!-- B10: Database Versions -->
    <section class="section">
      <h3>8. DATABASE VERSIONS</h3>
      <table class="methodology-table">
        <tr>
          <td>ClinVar</td>
          <td>2024-12 release</td>
        </tr>
        <tr>
          <td>gnomAD</td>
          <td>v4.1</td>
        </tr>
        <tr>
          <td>dbSNP</td>
          <td>Build 156</td>
        </tr>
        <tr>
          <td>ACMG SF List</td>
          <td>v3.2 (August 2023)</td>
        </tr>
        <tr>
          <td>ClinGen</td>
          <td>December 2024</td>
        </tr>
        <tr>
          <td>CADD</td>
          <td>v1.7 (GRCh38)</td>
        </tr>
        <tr>
          <td>REVEL</td>
          <td>v2.0</td>
        </tr>
        <tr>
          <td>SpliceAI</td>
          <td>v1.3.1</td>
        </tr>
      </table>
    </section>
    <div class="page-number">Page 5</div>
  </main>

  <!-- Page 6: Limitations + Appendix -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B11: Limitations -->
    <section class="section">
      <h3>9. LIMITATIONS</h3>
      <div style="font-size: 14px; line-height: 1.6; color: var(--text);">
        <ul style="margin: 12px 0; padding-left: 24px;">
          <li>The analysis is limited to the 81 genes on the ACMG SF v3.2 list.</li>
          <li>Certain variant types may not be detected, including large deletions/duplications, deep intronic variants, and complex rearrangements.</li>
          <li>Regions with low coverage (<20x) may have reduced sensitivity.</li>
          <li>Variants in pseudogenes, highly repetitive regions, or segmental duplications may be missed.</li>
          <li>Mosaicism below ~20% may not be detected.</li>
          <li>Clinical interpretation is based on current knowledge and may change as new data emerge.</li>
          <li>Negative results do not eliminate genetic risk for the conditions tested.</li>
        </ul>
      </div>
    </section>

    <!-- B12: Appendix -->
    <section class="section" style="break-inside: auto; page-break-inside: auto; overflow: visible;">
      <h3>10. APPENDIX</h3>
      
      <h4 style="margin: 20px 0 8px 0; font-size: 14px; font-weight: 600;">10.1 ACMG/AMP Variant Classification</h4>
      <table>
        <thead>
          <tr>
            <th>Classification</th>
            <th>Definition</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>Pathogenic</strong></td>
            <td>>99% certainty of being disease-causing</td>
          </tr>
          <tr>
            <td><strong>Likely Pathogenic</strong></td>
            <td>90-99% certainty of being disease-causing</td>
          </tr>
          <tr>
            <td><strong>VUS (Variant of Uncertain Significance)</strong></td>
            <td>Insufficient evidence to classify as pathogenic or benign (10-90%)</td>
          </tr>
          <tr>
            <td><strong>Likely Benign</strong></td>
            <td>1-10% certainty of being disease-causing</td>
          </tr>
          <tr>
            <td><strong>Benign</strong></td>
            <td><1% certainty of being disease-causing</td>
          </tr>
        </tbody>
      </table>

      <h4 style="margin: 24px 0 8px 0; font-size: 14px; font-weight: 600;">10.2 ACMG Evidence Criteria</h4>
      <table>
        <thead>
          <tr>
            <th>Code</th>
            <th>Strength</th>
            <th>Description</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>PVS1</td>
            <td>Very Strong</td>
            <td>Null variant in gene where LOF (Loss of Function) is mechanism</td>
          </tr>
          <tr>
            <td>PS1</td>
            <td>Strong</td>
            <td>Same amino acid change as established pathogenic variant</td>
          </tr>
          <tr>
            <td>PS3</td>
            <td>Strong</td>
            <td>Well-established functional studies show deleterious effect</td>
          </tr>
          <tr>
            <td>PM1</td>
            <td>Moderate</td>
            <td>Located in mutational hot spot or critical functional domain</td>
          </tr>
          <tr>
            <td>PM2</td>
            <td>Moderate</td>
            <td>Absent/extremely rare in population databases</td>
          </tr>
          <tr>
            <td>PP3</td>
            <td>Supporting</td>
            <td>Computational evidence supports deleterious effect</td>
          </tr>
          <tr>
            <td>PP5</td>
            <td>Supporting</td>
            <td>Reputable source reports variant as pathogenic</td>
          </tr>
        </tbody>
      </table>

      <h4 style="margin: 24px 0 8px 0; font-size: 14px; font-weight: 600;">10.3 ClinVar Review Status</h4>
      <table>
        <thead>
          <tr>
            <th>Stars</th>
            <th>Review Status</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><span class="clinvar-stars">★★★★</span> (4 stars)</td>
            <td>Expert panel reviewed</td>
          </tr>
          <tr>
            <td><span class="clinvar-stars">★★★</span> (3 stars)</td>
            <td>Multiple submitters, no conflicts</td>
          </tr>
          <tr>
            <td><span class="clinvar-stars">★★</span> (2 stars)</td>
            <td>Multiple submitters with conflicting interpretations</td>
          </tr>
          <tr>
            <td><span class="clinvar-stars">★</span> (1 star)</td>
            <td>Single submitter</td>
          </tr>
        </tbody>
      </table>

      <h4 style="margin: 24px 0 8px 0; font-size: 14px; font-weight: 600;">10.4 In Silico Prediction Tools</h4>
      <table style="table-layout: fixed; width: 100%;">
        <thead>
          <tr>
            <th style="width: 20%;">Tool</th>
            <th style="width: 80%;">Description & Thresholds</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td style="width: 20%; word-break: break-word; overflow-wrap: break-word; white-space: normal;"><strong>CADD</strong></td>
            <td style="width: 80%; word-break: break-word; overflow-wrap: break-word;">Combined Annotation Dependent Depletion. Score ≥20 suggests top 1% most deleterious; ≥30 suggests top 0.1%</td>
          </tr>
          <tr>
            <td style="width: 20%; word-break: break-word; overflow-wrap: break-word; white-space: normal;"><strong>REVEL</strong></td>
            <td style="width: 80%; word-break: break-word; overflow-wrap: break-word;">Rare Exome Variant Ensemble Learner. Score ≥0.5 suggests pathogenic; ≥0.75 high confidence pathogenic</td>
          </tr>
          <tr>
            <td style="width: 20%; word-break: break-word; overflow-wrap: break-word; white-space: normal;"><strong>SpliceAI</strong></td>
            <td style="width: 80%; word-break: break-word; overflow-wrap: break-word;">Deep learning splice prediction. Delta score ≥0.2 suggests splicing impact; ≥0.5 high confidence</td>
          </tr>
        </tbody>
      </table>
    </section>
    <div class="page-number">Page 6</div>
  </main>

  <!-- Page 7: Authorization / Signatures -->
  <main class="page">
    <header class="topbar">
      <div class="brand">
        <div class="mark">
          <img src="assets/medygenes_logosvg.svg" alt="MedyGenes" style="height: 40px; width: auto;">
        </div>
        <div>
          <div style="font-size:12px; color:var(--muted); letter-spacing:0.4px;">WHOLE GENOME SEQUENCING - Clinical Report</div>
        </div>
      </div>
      <div class="contact">
        <div>medigenes.co.il</div>
        <div>+1 (555) 321-9876</div>
        <div>support@medygenes.com</div>
        <div>Yigal Alon 94, Tel Aviv</div>
      </div>
    </header>

    <!-- B13: Authorization / Signatures -->
    <section class="section">
      <h3>11. AUTHORIZATION</h3>
      <div class="signature-block" style="display: grid; grid-template-columns: 1fr 1fr; gap: 40px;">
        <div class="signature-line">
          <div class="signature-name" style="margin-bottom: 8px;">Laboratory Director, MD, PhD, FACMG</div>
          <div style="margin-top: 24px; border-top: 1px solid var(--border); width: 100%; padding-top: 8px;">
            <div style="font-size: 12px; color: var(--muted); margin-bottom: 4px;">Date:</div>
            <div style="height: 20px; border-bottom: 1px solid var(--border);"></div>
          </div>
        </div>
        <div class="signature-line">
          <div class="signature-name" style="margin-bottom: 8px;">Genetic Counselor, MS, CGC</div>
          <div style="margin-top: 24px; border-top: 1px solid var(--border); width: 100%; padding-top: 8px;">
            <div style="font-size: 12px; color: var(--muted); margin-bottom: 4px;">Date:</div>
            <div style="height: 20px; border-bottom: 1px solid var(--border);"></div>
          </div>
        </div>
      </div>
    </section>

    <footer class="footer" style="flex-direction: column; align-items: center; gap: 8px; text-align: center; margin-top: 32px;">
      <div style="font-size: 11px; line-height: 1.6;">
        This report is confidential and intended solely for the referring healthcare provider and patient.<br>
        Genetic counseling is recommended for all positive findings.
      </div>
      <div style="font-size: 10px; color: var(--muted);">
        Page <span style="border-bottom: 1px solid var(--border); padding: 0 20px; display: inline-block;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> of <span style="border-bottom: 1px solid var(--border); padding: 0 20px; display: inline-block;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> | Report ID: WGS-2024-12345 | Generated: 2025-12-16
      </div>
    </footer>
    <div class="page-number">Page 7</div>
  </main>

</body>
</html>

